These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3493026)

  • 1. Interleukin-1 producing ability of leukaemia cells and its relationship to morphological diagnosis.
    Furukawa Y; Ohta M; Miura Y; Saito M
    Br J Haematol; 1987 Jan; 65(1):11-5. PubMed ID: 3493026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study.
    Resnitzky P; Shaft D
    Br J Haematol; 1994 Oct; 88(2):357-63. PubMed ID: 7803282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation.
    Vinante F; Rigo A; Tecchio C; Patuzzo C; Ricetti MM; Morosato L; Cassatella MA; Chilosi M; Pizzolo G
    Haematologica; 1996; 81(3):195-200. PubMed ID: 8767523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a bimodal relation between serum lysozyme and prognosis in 232 patients with acute myeloid leukaemia.
    Aström M; Bodin L; Hörnsten P; Wahlin A; Tidefelt U
    Eur J Haematol; 2003 Jan; 70(1):26-33. PubMed ID: 12631256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of lysozyme activity in serum, urine and blood smears from patients with haematological diseases].
    Labedzki L; Seché G; Lorbacher P
    Klin Wochenschr; 1977 Jul; 55(14):677-83. PubMed ID: 408556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
    da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
    Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells.
    Catovsky D; Galton DA
    J Clin Pathol; 1973 Jan; 26(1):60-9. PubMed ID: 4511938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte-associated acid phosphatase isoenzyme profiles as determined in acute myeloid leukaemia cells.
    Drexler HG; Gaedicke G; Klein M; Menon M; Minowada J
    Scand J Haematol; 1986 Mar; 36(3):239-45. PubMed ID: 3458296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 1 production by monocytic leukemia cells and its possible role in coagulation abnormalities.
    Furukawa Y; Ohta M; Miura Y; Saito M
    Leuk Res; 1991; 15(12):1133-7. PubMed ID: 1766261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a B-lymphoid differentiation antigen (CD 19) on acute non-lymphoblastic leukaemia cells.
    Campos L; Guyotat D; Gentilhomme O; Treille D; Fiere D; Germain D
    Eur J Haematol; 1987 Mar; 38(3):220-4. PubMed ID: 3297773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of acute myeloid leukaemia in trephine biopsies with special reference to lactoferrin.
    Al Safadi L; Köhler G; Schaefer HE
    Anticancer Res; 1998; 18(5B):3677-84. PubMed ID: 9854476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive production of interleukin 1 by human monocytic leukemia cell line JOSK-I and the production mechanism.
    Furukawa Y; Ohta M; Kasahara T; Miura Y; Saito M
    Cancer Res; 1987 May; 47(10):2589-93. PubMed ID: 3494502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human lysozyme (muramidase) on potassium handling by the perfused rat kidney. A mechanism for renal damage in human monocytic leukaemia.
    Mason DY; Howes DT; Taylor CR; Ross BD
    J Clin Pathol; 1975 Sep; 28(9):722-7. PubMed ID: 1058211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
    Robak T; Korycka A
    Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.
    San Miguel JF; Gonzalez M; Cañizo MC; Anta JP; Zola H; Lopez Borrasca A
    Br J Haematol; 1986 Nov; 64(3):547-60. PubMed ID: 3466644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of four human monocytoid leukemia cell lines (JOSK-I, -S, -M and -K) with capabilities of monocyte-macrophage lineage differentiation and constitutive production of interleukin 1.
    Ohta M; Furukawa Y; Ide C; Akiyama N; Utakoji T; Miura Y; Saito M
    Cancer Res; 1986 Jun; 46(6):3067-74. PubMed ID: 3486043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.